On the public citation graph

Virus-like particles: potential veterinary vaccine immunogens

https://doi.org/10.1016/j.rvsc.2011.10.018

0 signed · 161 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/btpr.187openalex-snapshot

Optimization of chimeric HIV‐1 virus‐like particle production in a baculovirus‐insect cell expression system

inferredcites →https://doi.org/10.1002/eji.1830261109openalex-snapshot

Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes

inferredcites →https://doi.org/10.1002/wnan.119openalex-snapshot

Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design

inferredcites →https://doi.org/10.1007/s00262-010-0895-0openalex-snapshot

Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles

inferredcites →https://doi.org/10.1007/s11262-007-0108-xopenalex-snapshot

Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles

inferredcites →https://doi.org/10.1016/j.biologicals.2005.08.006openalex-snapshot

Overview of marker vaccine and differential diagnostic test technology

inferredcites →https://doi.org/10.1016/j.copbio.2004.10.002openalex-snapshot

Virus-like particles as vaccines and vessels for the delivery of small molecules

inferredcites →https://doi.org/10.1016/j.copbio.2007.10.013openalex-snapshot

Virus-like particles—universal molecular toolboxes

inferredcites →https://doi.org/10.1016/j.jviromet.2011.07.012openalex-snapshot

Expression of an RSV-gag virus-like particle in insect cell lines and silkworm larvae

inferredcites →https://doi.org/10.1016/j.pep.2010.08.005openalex-snapshot

Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography

inferredcites →https://doi.org/10.1016/j.pep.2010.09.010openalex-snapshot

Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris

inferredcites →https://doi.org/10.1016/j.vaccine.2005.09.001openalex-snapshot

Prophylactic HPV vaccines: Reducing the burden of HPV-related diseases

inferredcites →https://doi.org/10.1016/j.vaccine.2008.02.037openalex-snapshot

Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2

inferredcites →https://doi.org/10.1016/j.vaccine.2008.05.066openalex-snapshot

Immunobiology of Human Papillomavirus Infection and Vaccination - Implications for Second Generation Vaccines

inferredcites →https://doi.org/10.1016/j.vaccine.2008.11.011openalex-snapshot

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

inferredcites →https://doi.org/10.1016/j.vaccine.2010.12.105openalex-snapshot

Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats

inferredcites →https://doi.org/10.1016/j.vaccine.2011.03.067openalex-snapshot

H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals

inferredcites →https://doi.org/10.1016/j.vetmic.2006.10.021openalex-snapshot

Assembly of feline calicivirus-like particle and its immunogenicity

inferredcites →https://doi.org/10.1016/j.vetmic.2009.09.057openalex-snapshot

Expression and self-assembly of virus-like particles from two genotypes of marine vesiviruses and development of an ELISA for the detection of antibodies

inferredcites →https://doi.org/10.1016/j.virol.2006.03.021openalex-snapshot

Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies

inferredcites →https://doi.org/10.1016/j.virol.2008.12.012openalex-snapshot

Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus

inferredcites →https://doi.org/10.1016/j.virusres.2011.02.006openalex-snapshot

Current strategies for subunit and genetic viral veterinary vaccine development

inferredcites →https://doi.org/10.1016/j.virusres.2011.04.009openalex-snapshot

Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice

inferredcites →https://doi.org/10.1016/j.ymeth.2006.07.018openalex-snapshot

Virus-like particles: Passport to immune recognition

inferredcites →https://doi.org/10.1016/s0079-6603(05)80004-2openalex-snapshot

Virus‐Like Particles: Models for Assembly Studies and Foreign Epitope Carriers

inferredcites →https://doi.org/10.1016/s0140-6736(07)60946-5openalex-snapshot

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

inferredcites →https://doi.org/10.1016/s0264-410x(00)00419-9openalex-snapshot

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals

inferredcites →https://doi.org/10.1016/s0264-410x(99)00351-5openalex-snapshot

HPV6b virus like particles are potent immunogens without adjuvant in man

inferredcites →https://doi.org/10.1016/s0966-842x(03)00208-7openalex-snapshot

Virus-like particles as immunogens

inferredcites →https://doi.org/10.1021/bp070472iopenalex-snapshot

Study of Detergent‐Mediated Liberation of Hepatitis B Virus‐like Particles from S. cerevisiae Homogenate: Identifying a Framework for the Design of Future‐Generation Lipoprotein Vaccine Processes

inferredcites →https://doi.org/10.1038/307178a0openalex-snapshot

Human hepatitis B vaccine from recombinant yeast

inferredcites →https://doi.org/10.1038/icb.2010.161openalex-snapshot

Cross‐presentation of epitopes on virus‐like particles via the MHC I receptor recycling pathway

inferredcites →https://doi.org/10.1051/vetres:2006056openalex-snapshot

Feline calicivirus

inferredcites →https://doi.org/10.1051/vetres:2008023openalex-snapshot

Bluetongue virus: virology, pathogenesis and immunity

inferredcites →https://doi.org/10.1073/pnas.0405924101openalex-snapshot

Therapeutic vaccines: Realities of today and hopes for tomorrow

inferredcites →https://doi.org/10.1073/pnas.2237038100openalex-snapshot

Ebola virus-like particles protect from lethal Ebola virus infection

inferredcites →https://doi.org/10.1073/pnas.94.14.7503openalex-snapshot

Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells

inferredcites →https://doi.org/10.1073/pnas.95.16.9477openalex-snapshot

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

inferredcites →https://doi.org/10.1080/02648725.2001.10648009openalex-snapshot

Use of the Baculovirus Expression System for the Generation of Virus-Like Particles

inferredcites →https://doi.org/10.1089/vim.2009.0017openalex-snapshot

Virus-Like Particle Vaccine Comprised of the HA, NA, and M1 Proteins of an Avian Isolated H5N1 Influenza Virus Induces Protective Immunity Against Homologous and Heterologous Strains in Mice

inferredcites →https://doi.org/10.1093/nar/21.5.1219openalex-snapshot

Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells

inferredcites →https://doi.org/10.1099/0022-1317-79-2-333openalex-snapshot

Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.

inferredcites →https://doi.org/10.1099/vir.0.18612-0openalex-snapshot

Down-regulation of MHC class I expression by equine herpesvirus-1

inferredcites →https://doi.org/10.1099/vir.0.2008/002089-0openalex-snapshot

Bluetongue virus: dissection of the polymerase complex

inferredcites →https://doi.org/10.1099/vir.0.83267-0openalex-snapshot

Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1

inferredcites →https://doi.org/10.1111/j.0818-9641.2004.01271.xopenalex-snapshot

Vaccines that facilitate antigen entry into dendritic cells

inferredcites →https://doi.org/10.1128/jvi.00050-06openalex-snapshot

Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses

inferredcites →https://doi.org/10.1128/jvi.00726-06openalex-snapshot

Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles

inferredcites →https://doi.org/10.1128/jvi.01709-09openalex-snapshot

Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology

inferredcites →https://doi.org/10.1128/jvi.01931-09openalex-snapshot

Assembly and Biological and Immunological Properties of Newcastle Disease Virus-Like Particles

inferredcites →https://doi.org/10.1128/jvi.64.12.5695-5700.1990openalex-snapshot

Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins

inferredcites →https://doi.org/10.1128/jvi.64.4.1530-1536.1990openalex-snapshot

Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV

inferredcites →https://doi.org/10.1128/jvi.73.4.2739-2744.1999openalex-snapshot

Intranasal Delivery of Recombinant Parvovirus-Like Particles Elicits Cytotoxic T-Cell and Neutralizing Antibody Responses

inferredcites →https://doi.org/10.1128/jvi.76.20.10138-10146.2002openalex-snapshot

Newcastle Disease Virus (NDV) Marker Vaccine: an Immunodominant Epitope on the Nucleoprotein Gene of NDV Can Be Deleted or Replaced by a Foreign Epitope

inferredcites →https://doi.org/10.1146/annurev-pharmtox-061008-103129openalex-snapshot

Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases

inferredcites →https://doi.org/10.1146/annurev.immunol.15.1.235openalex-snapshot

NEUTRALIZING ANTIVIRAL B CELL RESPONSES

inferredcites →https://doi.org/10.1159/000150482openalex-snapshot

Virus-Like Particles Induce MHC Class I-Restricted T-Cell Responses

inferredcites →https://doi.org/10.1186/1472-6750-10-30openalex-snapshot

Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production

inferredcites →https://doi.org/10.1186/1743-422x-5-82openalex-snapshot

Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins

inferredcites →https://doi.org/10.1186/1743-422x-7-166openalex-snapshot

Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli

inferredcites →https://doi.org/10.1186/1743-422x-7-279openalex-snapshot

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever

inferredcites →https://doi.org/10.1186/1743-422x-8-170openalex-snapshot

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig

inferredcites →https://doi.org/10.1371/journal.pone.0009784openalex-snapshot

Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus

inferredcites →https://doi.org/10.1515/bc.2008.064openalex-snapshot

The coming of age of virus-like particle vaccines

inferredcites →https://doi.org/10.1586/14760584.6.3.381openalex-snapshot

Virus-like particles: flexible platforms for vaccine development

inferredcites →https://doi.org/10.1586/erv.10.115openalex-snapshot

Virus-like particles in vaccine development

inferredcites →https://doi.org/10.1586/erv.11.24openalex-snapshot

Insect cell technology is a versatile and robust vaccine manufacturing platform

inferredcites →https://doi.org/10.1637/8644-020409-reg.1openalex-snapshot

Differentiation of Infected and Vaccinated Animals (DIVA) Using the NS1 Protein of Avian Influenza Virus

inferredcites →https://doi.org/10.2174/1389201053167202openalex-snapshot

Recombinant Virus Like Particles as Drug Delivery System

inferredcites →https://doi.org/10.2174/157016210791208659openalex-snapshot

Virus-Like Particles as Particulate Vaccines

inferredcites →https://doi.org/10.2217/fvl.10.50openalex-snapshot

Newcastle Disease Virus-like Particles as a Platform for the Development of Vaccines for Human and Agricultural Pathogens

inferredcites →https://doi.org/10.2222/jsv.58.155openalex-snapshot

Protection against uterine cervical cancer by HPV vaccines

inferredcites →https://doi.org/10.3382/ps.2010-01258openalex-snapshot

Inactivated H9N2 avian influenza virus vaccine with gel-primed and mineral oil-boosted regimen could produce improved immune response in broiler breeders

inferredcites →https://doi.org/10.4161/hv.4.1.5559openalex-snapshot

Virus‑like particles as a vaccine delivery system: Myths and facts

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4197210openalex-extracted

Poly(I:C) and CpG Improve the Assembly of Foot-and-Mouth Disease Virus-Like Particles and Immune Response in Mice

inferred← citeshttps://doi.org/10.1002/bip.22759openalex-snapshot

Different applications of virus‐like particles in biology and medicine: Vaccination and delivery systems

inferred← citeshttps://doi.org/10.1002/elsc.201300131openalex-snapshot

Single‐use wave‐mixed versus stirred bioreactors for insect‐cell/BEVS‐based protein expression at benchtop scale

inferred← citeshttps://doi.org/10.1007/10_2013_186openalex-snapshot

Fast Single-Use VLP Vaccine Productions Based on Insect Cells and the Baculovirus Expression Vector System: Influenza as Case Study

inferred← citeshttps://doi.org/10.1007/s12033-012-9598-4openalex-snapshot

Construction and Characterization of Virus-Like Particles: A Review

inferred← citeshttps://doi.org/10.1007/s12033-015-9891-0openalex-snapshot

Potato Virus M-Like Nanoparticles: Construction and Characterization

inferred← citeshttps://doi.org/10.1016/b978-0-12-813627-0.00015-6openalex-snapshot

Technologies that generate and modify virus-like particles for medical diagnostic and therapy purposes

inferred← citeshttps://doi.org/10.1016/b978-0-12-816328-3.00006-4openalex-snapshot

Emerging Trends in the Development of Plant Virus-Based Nanoparticles and Their Biomedical Applications

inferred← citeshttps://doi.org/10.1016/b978-0-323-68299-2.00012-5openalex-snapshot

Nonliving vaccines

inferred← citeshttps://doi.org/10.1016/b978-0-443-33572-3.00018-7openalex-snapshot

Bovine vaccines

inferred← citeshttps://doi.org/10.1016/j.bej.2019.107373openalex-snapshot

Production and characterization of Hantaan virus-like particles from baculovirus expression system

inferred← citeshttps://doi.org/10.1016/j.biologicals.2017.11.002openalex-snapshot

Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles

inferred← citeshttps://doi.org/10.1016/j.biori.2017.10.001openalex-snapshot

The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches

inferred← citeshttps://doi.org/10.1016/j.biotechadv.2020.107547openalex-snapshot

The biomedical and bioengineering potential of protein nanocompartments

inferred← citeshttps://doi.org/10.1016/j.btre.2015.12.001openalex-snapshot

Transient Bluetongue virus serotype 8 capsid protein expression in Nicotiana benthamiana

inferred← citeshttps://doi.org/10.1016/j.btre.2021.e00605openalex-snapshot

Hepatitis B core-based virus-like particles: A platform for vaccine development in plants

inferred← citeshttps://doi.org/10.1016/j.cimid.2013.02.002openalex-snapshot

Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design

inferred← citeshttps://doi.org/10.1016/j.inmuno.2012.08.002openalex-snapshot

Virus-like particle-based vaccines for animal viral infections

inferred← citeshttps://doi.org/10.1016/j.jconrel.2013.08.026openalex-snapshot

Production and biomedical applications of virus-like particles derived from polyomaviruses

inferred← citeshttps://doi.org/10.1016/j.jviromet.2014.11.018openalex-snapshot

Peste des petits ruminants virus-like particles induce both complete virus-specific antibodies and virus neutralizing antibodies in mice

inferred← citeshttps://doi.org/10.1016/j.jviromet.2016.02.011openalex-snapshot

Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli

inferred← citeshttps://doi.org/10.1016/j.jviromet.2017.05.003openalex-snapshot

Prokaryotic expression of a codon-optimized capsid gene from duck circovirus and its application to an indirect ELISA

inferred← citeshttps://doi.org/10.1016/j.micpath.2020.104130openalex-snapshot

Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles

inferred← citeshttps://doi.org/10.1016/j.rvsc.2015.07.012openalex-snapshot

Plant-based porcine reproductive and respiratory syndrome virus VLPs induce an immune response in mice

inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.02.031openalex-snapshot

Rabies virus-like particles expressed in HEK293 cells

inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.04.038openalex-snapshot

Foot-and-mouth disease: Technical and political challenges to eradication

inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.03.088openalex-snapshot

Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate

inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.02.047openalex-snapshot

Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B

inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126549openalex-snapshot

The stability of PCV2 virus-like particles from mammalian cells and challenges for biotechnological applications

inferred← citeshttps://doi.org/10.1016/j.vetimm.2018.01.012openalex-snapshot

Oral immunization with cell-free self-assembly virus-like particles against orange-spotted grouper nervous necrosis virus in grouper larvae, Epinephelus coioides

inferred← citeshttps://doi.org/10.1016/j.virol.2022.12.016openalex-snapshot

Poly(I:C) and CpG improve the assembly of foot-and-mouth disease virus-like particles and immune response in mice

inferred← citeshttps://doi.org/10.1016/j.virusres.2014.01.004openalex-snapshot

Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA)

inferred← citeshttps://doi.org/10.1021/acs.chemrev.1c00877openalex-snapshot

Protein Cages: From Fundamentals to Advanced Applications

inferred← citeshttps://doi.org/10.1039/d1tb02719kopenalex-snapshot

Bio-mineralization of virus-like particles by metal–organic framework nanoparticles enhances the thermostability and immune responses of the vaccines

inferred← citeshttps://doi.org/10.1079/9781800625761.0005openalex-snapshot

Adaptive Immunity Elicited by Vaccination

inferred← citeshttps://doi.org/10.1080/02648725.2022.2116309openalex-snapshot

A comprehensive review and meta-analysis of recent advances in biotechnology for plant virus research and significant accomplishments in human health and the pharmaceutical industry

inferred← citeshttps://doi.org/10.1089/crispr.2024.0036openalex-snapshot

Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects

inferred← citeshttps://doi.org/10.1111/pbi.12440openalex-snapshot

Plant‐produced viral bovine vaccines: what happened during the last 10 years?

inferred← citeshttps://doi.org/10.1159/000442751openalex-snapshot

Detection of the Assembly and Disassembly of PCV2b Virus-Like Particles Using Fluorescence Spectroscopy Analysis

inferred← citeshttps://doi.org/10.1159/000515719openalex-snapshot

Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles

inferred← citeshttps://doi.org/10.1186/s12917-025-05002-5openalex-snapshot

Development of an indirect ELISA for Duck circovirus detection based on prokaryotically expressed antigen

inferred← citeshttps://doi.org/10.1186/s12934-018-0868-0openalex-snapshot

Establishment of a yeast-based VLP platform for antigen presentation

inferred← citeshttps://doi.org/10.1186/s12951-018-0363-0openalex-snapshot

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide

inferred← citeshttps://doi.org/10.1186/s12951-024-02311-zopenalex-snapshot

The quest for nanoparticle-powered vaccines in cancer immunotherapy

inferred← citeshttps://doi.org/10.1186/s40643-016-0114-8openalex-snapshot

Regulation of porcine circovirus type 2-like particles expressed in baculovirus expression system

inferred← citeshttps://doi.org/10.1371/journal.pone.0056417openalex-snapshot

Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine

inferred← citeshttps://doi.org/10.1371/journal.pone.0080762openalex-snapshot

Protective Efficacy of a Human Endogenous Retrovirus Envelope-Coated, Nonreplicable, Baculovirus-Based Hemagglutin Vaccine against Pandemic Influenza H1N1 2009

inferred← citeshttps://doi.org/10.1371/journal.pone.0129761openalex-snapshot

Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant

inferred← citeshttps://doi.org/10.14790/ijams.12.111openalex-snapshot

An equitable approach is necessary to win a war against the global COVID-19 pandemic

inferred← citeshttps://doi.org/10.21203/rs.2.17916/v1openalex-snapshot

Hepatitis E virus truncated capsid protein as a potential carrier of exogenous antigens for the development of chimeric virus-like particle vaccines

inferred← citeshttps://doi.org/10.2174/1381612811319310011openalex-snapshot

The Use of Transient Expression Systems for the Rapid Production of Virus-like Particles in Plants

inferred← citeshttps://doi.org/10.2174/2211738508666200910101504openalex-snapshot

Nanotechnology and Animal Health

inferred← citeshttps://doi.org/10.31080/asvs.2022.04.0333openalex-snapshot

Modern Vaccines- an Overview

inferred← citeshttps://doi.org/10.33073/pjm-2015-001openalex-snapshot

Virus Like Particles as Immunogens and Universal Nanocarriers

inferred← citeshttps://doi.org/10.3389/fimmu.2020.01100openalex-snapshot

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs

inferred← citeshttps://doi.org/10.3389/fpls.2021.717952openalex-snapshot

Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease

inferred← citeshttps://doi.org/10.3389/fvets.2023.1116661openalex-snapshot

Development of modern immunization agent against bovine papillomavirus type 1 infection based on BPV1 L1 recombinant protein

inferred← citeshttps://doi.org/10.3389/fviro.2021.756559openalex-snapshot

Expression, Purification, and Characterization of Bovine Leukemia Virus-Like Particles Produced in Drosophila S2 Cells

inferred← citeshttps://doi.org/10.3390/ani11061819openalex-snapshot

Current Status for Controlling the Overlooked Caprine Fasciolosis

inferred← citeshttps://doi.org/10.3390/pathogens9120996openalex-snapshot

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants

inferred← citeshttps://doi.org/10.3390/v11100918openalex-snapshot

Peste des Petits Ruminants Virus-Like Particles Induce a Potent Humoral and Cellular Immune Response in Goats

inferred← citeshttps://doi.org/10.3390/v13081499openalex-snapshot

Exosome-Based Vaccines: Pros and Cons in the World of Animal Health

inferred← citeshttps://doi.org/10.3390/v14081624openalex-snapshot

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles

inferred← citeshttps://doi.org/10.3390/v6124839openalex-snapshot

Virus-Like Particles of Chimeric Recombinant Porcine Circovirus Type 2 as Antigen Vehicle Carrying Foreign Epitopes

inferred← citeshttps://doi.org/10.3390/vaccines10071124openalex-snapshot

Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance

inferred← citeshttps://doi.org/10.3390/vaccines11020462openalex-snapshot

Oral and Subcutaneous Immunization with a Plant-Produced Mouse-Specific Zona Pellucida 3 Peptide Presented on Hepatitis B Core Antigen Virus-like Particles

inferred← citeshttps://doi.org/10.3390/vaccines12020212openalex-snapshot

Porcine Epidemic Diarrhea: Insights and Progress on Vaccines

inferred← citeshttps://doi.org/10.3390/vaccines8030532openalex-snapshot

Potent Protective Immune Responses to Senecavirus Induced by Virus-Like Particle Vaccine in Pigs

inferred← citeshttps://doi.org/10.3390/vaccines9020098openalex-snapshot

Immunogenicity and Protective Activity of Pigeon Circovirus Recombinant Capsid Protein Virus-Like Particles (PiCV rCap-VLPs) in Pigeons (Columba livia) Experimentally Infected with PiCV

inferred← citeshttps://doi.org/10.3390/vaccines9030251openalex-snapshot

Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus

inferred← citeshttps://doi.org/10.3390/vaccines9090992openalex-snapshot

Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines

inferred← citeshttps://doi.org/10.3923/ijds.2020.114.122openalex-snapshot

Better Understanding of Important Aspects Associated with Vaccines Development for Controlling Viral Diseases in Animals

inferred← citeshttps://doi.org/10.3989/arbor.2014.768n4008openalex-snapshot

La biotecnología en sanidad animal

inferred← citeshttps://doi.org/10.4018/978-1-4666-6363-3.ch012openalex-snapshot

Vaccine Nanocarriers

inferred← citeshttps://doi.org/10.4018/978-1-5225-3158-6.ch058openalex-snapshot

Vaccine Nanocarriers

inferred← citeshttps://doi.org/10.4155/pbp.14.39openalex-snapshot

Development of picornavirus-like particle vaccines

inferred← citeshttps://doi.org/10.47278/book.ahp/2022.63openalex-snapshot

VACCINATION AND IMMUNOLOGY IN LARGE ANIMALS

inferred← citeshttps://doi.org/10.47278/book.vpph/2021.037openalex-snapshot

Recent Trends in Immunology and Vaccination Against Newcastle Disease Virus

inferred← citeshttps://doi.org/10.47278/book.zoon/2023.169openalex-snapshot

Significance of Nanoparticles as Prophylactic and Treatment Option for Bacterial and Reverse Zoonosis

inferred← citeshttps://doi.org/10.47749/t/unicamp.2019.1094106openalex-snapshot

Desenvolvimento de nanocompósitos de óxido de grafeno decorado com nanopartículas de sílica mesoporosa como nanocarreadores de fármacos

inferred← citeshttps://doi.org/10.48160/25913530di05.58openalex-snapshot

Las partículas similares a virus (VLPs, virus-likeparticles) y su empleo en vacunología

inferred← citeshttps://doi.org/10.52976/vansaglik.908047openalex-snapshot

Virus Benzeri Partiküller ve Aşıların Geliştirilmesinde Önemi

inferred← citeshttps://doi.org/10.7314/apjcp.2012.13.12.5917openalex-snapshot

Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine Development

inferred← citeshttps://doi.org/10.7774/cevr.2012.1.1.18openalex-snapshot

A review of vaccine development and research for industry animals in Korea

inferred← citeshttps://doi.org/10.7774/cevr.2014.3.2.133openalex-snapshot

Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use

inferred← citeshttps://doi.org/10.7774/cevr.2016.5.1.12openalex-snapshot

Recent vaccine technology in industrial animals

inferred← citeshttps://doi.org/10.9734/jpri/2022/v34i8a35476openalex-snapshot

Nanobiotechnology and its Application in Vaccine Delivery

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.